The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU ASCO Review 2019: FDA Approval of Daratumumab in Combination with Len-Dex for Newly Diagnosed, Transplant-Ineligible Patients with Multiple Myeloma

0 views
August 19, 2019
Comments 0
Login to view comments. Click here to Login